Sun Pharma (Netherlands) B.V. 3/A
3/A · Krystal Biotech, Inc. · Filed Sep 25, 2017
Insider Transaction Report
Form 3/AAmended
Sun Pharma (Netherlands) B.V.
10% Owner
Holdings
Series A Convertible Preferred Stock
→ Common Stock (914,107 underlying)
Footnotes (2)
- [F1]The Series A convertible preferred stock will automatically convert on a one-to-one basis into 914,107 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.
- [F2]These shares were incorrectly included in the Non-Derivative Securities table in the reporting person's original Form 3, filed September 19, 2017.